Renalytix plc Equity Method Investment, Other than Temporary Impairment
Renalytix plc (RNLXY) reported Equity Method Investment, Other than Temporary Impairment of $0 for the 12-month period ending 2023-06-30, per its 10-K filed 2023-09-28.
Discontinued › Income Statement › Other Income
us-gaap:EquityMethodInvestmentOtherThanTemporaryImpairment · last filed 2023-09-28
- Renalytix plc equity method investment, other than temporary impairment for fiscal 2023 was $0.00.
| Period end | Equity Method Investment, Other than Temporary Impairment 12 month |
|---|---|
| 2023-06-30 | $0.00 10-K · filed 2023-09-28 |